Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ATHX Company Profile and Key Details

NASDAQ : ATHX

Athersys, Inc.

$0.01
-0.0068-33.50%
At Close 4:00 PM
Not Actively Trading
$0.03
0.01+74.07%
Pre-Market 09:30 AM
63.78
BESG ScoreESG Rating

ATHX Stock Price Chart

Stock Price Today

Athersys, Inc. (ATHX) stock declined over -33.50%, trading at $0.01 on NASDAQ, down from the previous close of $0.02. The stock opened at $0.02, fluctuating between $0.01 and $0.02 in the recent session.

Stock Snapshot

0.0203
Prev. Close
0.02
Open
0
Market Cap
0
Number of Shares
0.0116
Day Low
0.0212
Day High
-0.008181818181818182
P/E Ratio
99.08%
Free Float in %
-1.65
EPS (TTM)
-1.49
Book Value
-1.01
Cash Flow per Share
6.46M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 05, 20240.020.030.020.02881.03K
Feb 02, 20240.020.030.020.02362.67K
Feb 01, 20240.020.030.020.02470.64K
Jan 31, 20240.030.030.020.031.34M
Jan 30, 20240.030.030.020.03426.46K
Jan 29, 20240.020.030.020.032.24M
Jan 26, 20240.030.030.020.021.52M
Jan 25, 20240.030.030.020.031.96M
Jan 24, 20240.030.030.030.031.77M
Jan 23, 20240.030.040.020.032.53M
Jan 22, 20240.020.030.020.022.54M
Jan 19, 20240.020.030.020.023.1M
Jan 18, 20240.030.040.020.025.91M
Jan 17, 20240.010.040.010.0310.08M
Jan 16, 20240.010.020.010.013.49M
Jan 12, 20240.010.010.010.01686.16K
Jan 11, 20240.010.010.010.01582.08K
Jan 10, 20240.010.010.000.011.91M
Jan 09, 20240.010.010.010.013.38M
Jan 08, 20240.020.020.010.016.46M

Contact Details

Cleveland, OH 44115-2634

United States

Website: https://www.athersys.comContact: 216 431 9900

About Company

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

Company Information

Employees24
Beta-0.9
Sales or Revenue$5.33M
5Y Sales Change%17%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Athersys, Inc. (ATHX) stock price?

Athersys, Inc. (NASDAQ: ATHX) stock price is $0.01 in the last trading session. During the trading session, ATHX stock reached the peak price of $0.02 while $0.01 was the lowest point it dropped to. The percentage change in ATHX stock occurred in the recent session was -33.5% while the dollar amount for the price change in ATHX stock was -$0.01.

ATHX's industry and sector of operation?

The NASDAQ listed ATHX is part of Biotechnology industry that operates in the broader Healthcare sector. Athersys, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ATHX?

Ms. Alison O'Sullivan M.B.A.
Vice President of HR
Mr. David Russ M.B.A.
Vice President of Supply Chain, Fin. & Admin.
Dr. Sarah Busch Ph.D.
Vice President of Regenerative Medicine & Head of Bus. Devel.
Ms. Maia A. Hansen M.B.A., M.S.
Chief Operating Officer
Ms. Z. Kasey Rosado
Interim Chief Financial Officer
Dr. Manal Morsy M.B.A., M.D., PH.D.
Executive Vice President & Head of Global Regulatory Affairs
Ms. Ellen Gurley
Mang. of Corporation Communications and Investor Relations
Mr. Rakesh Ramachandran MS
Head of Information Technology & Communications and Vice President
Dr. Robert Mays Ph.D.
Executive Vice President, Head of Regenerative Medicine & Neuroscience Programs
Mr. James Glover B.S., P.M.P.
Executive Vice President & Head of Manufacturing
Mr. Daniel A. Camardo M.B.A.
Chief Executive Officer, Sec., Principal Accounting Officer & Director
Senthil Ranganathan Ph.D.
Vice President of Technical Operations

How ATHX did perform over past 52-week?

ATHX's closing price is 200% higher than its 52-week low of $0.00 where as its distance from 52-week high of $1.99 is -99.32%.

How many employees does ATHX have?

Number of ATHX employees currently stands at 24.

Link for ATHX official website?

Official Website of ATHX is: https://www.athersys.com

How do I contact ATHX?

ATHX could be contacted at phone 216 431 9900 and can also be accessed through its website. ATHX operates from 3201 Carnegie Avenue, Cleveland, OH 44115-2634, United States.

How many shares of ATHX are traded daily?

ATHX stock volume for the day was 6.46M shares. The average number of ATHX shares traded daily for last 3 months was 1.77M.

What is the market cap of ATHX currently?

The market value of ATHX currently stands at $0.00 with its latest stock price at $0.01 and 0 of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph